51
Participants
Start Date
December 19, 2011
Primary Completion Date
July 31, 2016
Study Completion Date
September 30, 2016
4.0mg Folic Acid received through participation in FACT (NCT01355159)
"Participants in this study received either daily high-dose folic acid supplementation during pregnancy OR placebo through their participation in FACT (NCT01355159). Details of the FACT Folic Acid intervention are provided below:~Folic Acid 1.0 mg x 4 tablets will be taken daily by oral administration. The majority of women in the study will routinely take 1.0 mg folic acid in a prenatal vitamin supplement, as recommended by their primary obstetrical provider; the study requirements do not require that participants change their practice. Therefore the actual total daily dose may be up to 5.1 mg of folic acid"
Placebo received through participation in FACT
"Participants in this study received either daily high-dose folic acid supplementation during pregnancy OR placebo through their participation in FACT (NCT01355159). Details of the FACT Folic Acid placebo are provided below:~Placebo x 4 tablets will be taken daily by oral administration."
The Moncton Hospital, Moncton
Kingston General Hospital, Kingston
The Ottawa Hospital, Ottawa
Health Canada, Ottawa
Lead Sponsor
Ottawa Hospital Research Institute
OTHER